Icon

DAYVIGO (nda212028)- (5MG,10MG)

LEMBOREXANT EISAI INC
5MG,10MG
No No
2035-Oct-21 2025-Apr-07
None None
None No
DAYVIGO is an orexin receptor antagonist indicated for the treatment of adult patients with insomnia, characterized by difficulties with sleep onset and/or sleep maintenance.
0 0 0
Total Other Developers 1
Drugs with Suitability No
5MG ** ** Up - -
10MG ** ** Up - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.